µÚËľüÒ½´óѧһ¾Å¾Å¶þÄê¹¥¶Á²©Ê¿Ñ§Î»Ñо¿ÉúÈëѧÊÔÌâ ѧ¿Æ×¨Òµ£º .B:ZyTI
iBSM
\ n
´«È¾²¡Ñ§ ¿¼ÊÔ¿ÆÄ¿: ÃâÒßѧ @N4_){s*
tOiz tYu
Ò». Ãû´Ê½âÊÍ(ÿÌâ4·Ö,¹²32·Ö) R| ?Q&F_$
$oBs%.Jp
1. ICAM-1 ~)U50.CH
J=`
8
2. interleukin 12(IL-12) <fvu)
f
qVC+q8
3. tumor infiltrating lymphocyte $hhXsu=
7;EDU
4. TCR/CD3 complex Q,3kaR@O
2{79,Js0
5. hematopoietin receptor family s2O()u-
Msqqjhoy
6. individual idiotype(IdI) !mlfG"FE
<_YdN)x
7. integrin gi!_Nz
#X-C~*|>j
8. colony-stimulatory factor (CSF) 5#.m
'a)
pJHdY)Cz
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© |T<aWZb^=
Kv@P Uzu
1. ÃâÒßÇòµ°°×ÖØÁ´µÄ»ùÒòÈçºÎ½øÐÐÀà±ðת»»(class switching )? $s7U
|F,I
=yod
2. ¼òÊöɱÉËÐÔTϸ°û(Tc)ɱÉ˲¡¶¾¸ÐȾ°Ðϸ°ûµÄ»úÀí¡£ o +$v0vg%T
BN 9e S
3. ÉúÎïÓ¦´ðµ÷½Ú¼Á( biological response modifier,BRM)Ö÷ÒªÓÐÄļ¸Àà?¼òÒª½éÉÜÔÚ´«È¾ÐÔ¼²²¡·ÀÖÎÖеÄ×÷Óᣠ~0PzRS^o
U"GxXrl
4. ¼òÊö¿¹ÔÌá³Êϸ°û(APC)Ó븨ÖúÐÔTϸ°û(Th)Ï໥×÷ÓõĹØÏµ¡£ 1M`E.Ztw*
S^%3Vf}
Èý. ÎÊ´ðÌâ(ÿÌâ18·Ö,¹²36·Ö) }g +kU1y
cO5F=ZxR
1. ÊÔÊö¸ÉÈÅËØµÄ·ÖÀ༰ÆäÉúÎïѧ×÷ÓÃÌØµã¡£Ö÷Òª¿ÉÒÔÖÎÁÆÄÄЩ´«È¾ÐÔ¼²²¡?¼òÊö¸ÉÈÅËØ¼ì²âµÄ·½·¨ºÍÔÀí¡£ Q:P)g#suc
kK75 (x
2. ºÎΪ»ùÒò¹¤³Ì¿¹Ìå?Ŀǰ¹úÄÚÍâÔÚ»ùÒò¹¤³Ì¿¹ÌåÑо¿ÖÐÓÐÄÄЩÖ÷Òª½øÕ¹? µÚËľüÒ½´óѧһ¾Å¾ÅÈýÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ѧ¿Æ×¨Òµ: ´«È¾²¡Ñ§¡¢ Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿: ÃâÒßѧ Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© 1. CD4 2. T cell receptor(TCR) XM\\
Imw
og";mC
3. immunoglobulin superfamily (IgSF) 89M'klZ
Au2?f~#Fv
4. selectin UBL{3s^"
Wc@
,#v
5. anti-idiotypic antibody (¦ÁId) 6Q :Wo)^!
/si<Fp)z
6. major histocompatibility complex(MHC) ]Za[]E8MD
3wfcGQn|sD
7. immunotolerance T`e`nQ0nn
O|t>.<T?
8. biological reponse modifier(BRM) (xo`*Q,+
1@Jp3wW
9. immune reponse gene (Ir gene) $IQPB_:
{@2+oOuYfN
10. reshaped antibody (or reconstituted antibody) o9}\vN0F
%?[gBf[y
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© A O5&Y.A#
;B@#,6t/
1. ¼òÊö°×ϸ°û½éËØ6(IL-6)Ö÷ÒªµÄÉúÎïѧ»îÐÔ¡£ 8gavcsVE[
zg ,=A?
2. ϸ°û¶¾ÐÔTÁܰÍϸ°û(Tc»òCTL)Ó뿹ÌåÒÀÀµµÄϸ°û½éµ¼µÄϸ°û¶¾(ADCC)ɱÉË»úÀíÓкβ»Í¬? +.~K=.O)
f
+9eB
3. ¼òÊöµÚ¢ôÐÍ(³Ù·¢ÐÍ)±ä̬·´Ó¦µÄ·¢Éú»úÀí¡£ (l
%?YME
`<g]p-=":
4. NKϸ°ûÓÐÄÄЩÖ÷ÒªµÄ±íÃæ±ê¼Ç?NKϸ°ûÓÐÄÄЩÖ÷ÒªµÄÉúÎïѧ»îÐÔ? |fKT@2(
9}QIqH\p
Èý. ÎÊ´ðÌâ(ÿÌâ14·Ö,¹²28·Ö) ¹©´«È¾²¡Ñ§×¨ÒµÊÔÌ⣺ Lk|`\I
T
-Kg.w*\H7/
1. »úÌåÓÐÄÄЩÃâÒßϸ°ûºÍÃâÒß·Ö×Ó²ÎÓ뿹²¡¶¾¸ÐȾ?ËüÃÇÊÇÈçºÎ·¢»Ó²¡¶¾ÃâÒß×÷ÓõÄ? EmaS/]X[
+ZbNSN=
2. Ŀǰµ¥¿Ë¡¿¹ÌåÔÚ²¡¶¾Ñ§ÖÐÓÐÄÄЩÖ÷ÒªÓÃ;?½ñºó¿ÉÄÜÓÐÄÄЩÖ÷ÒªµÄ·¢Õ¹·½Ïò? ¡¡ (W#CDw<ja
CmXLD} L_x
¹©Ïû»¯ÄÚ¿Æ×¨ÒµÊÔÌ⣺ '4M{Xn}@
W! $U{=
1. ĿǰÌåÄÚºÍÌåÍâ¼ì²âÖ×Áö»¼ÕßÃâÒß¹¦Äܵķ½·¨Ö÷ÒªÓÐÄÄЩ?·Ö±ðÐðÊöÿÖÖ·½·¨µÄÔÀíºÍ½á¹û²â¶¨? k6"(\d9o
MhA4C 8
2. Ŀǰµ¥¿Ë¡¿¹ÌåÔÚÖ×ÁöѧÖÐÓÐÄÄЩÖ÷ÒªµÄÓÃ;?½ñºó¿ÉÄÜÓÐÄÄЩÖ÷ÒªµÄ·¢Õ¹·½Ïò? ¡¡ "Bwz
Fh
\)5mO 8w
µÚËľüÒ½´óѧһ¾Å¾ÅËÄÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ѧ¿Æ×¨Òµ: LpY{<:y
3\4e{3$
´«È¾²¡Ñ§¡¢ Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿: ZxSnqbyA*
Q3%]
̉񧄤 Z$INmo6
vE,^K6q0`
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© @]IRB1X
k62s|VeU
1. CD8 }F0<8L6%
ML'y`S
2. T cell receptor ¦Á and ¦Â chain (TCR¦Á¦Â ) d
:|x e :
1OExa<Zq
3. immunoglobulin fold(Ig fold) '*L6@e#U
4v/MZ:%C`
4. cadherin (Ca-dependent cell adhesion moleculers) t O.5
vGlVr.)
5. idiotype-anti-idiotypic antibody immune network theory T0dD:s N
'W
hJ}Uo\
6. HLA class II antigen C{m%]jKH
{|>Wwa2e
7. complementarity-determining region (CDR) wH!$TAZ:Yw
M1WD^?tKQ.
8. perforin(or pore-forming protein ,PFP) ]w>o=<?b
X-nC2[tu'W
9. high affinity IL-2 receptor jr0j0$BF
FHU6o910
10. artificial active immunization ";=!PL
-GFZFi
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© /a^
R$RHl'
8O]`3oa>
1. ¼òÊö°×ϸ°û½éËØ2(IL-2)Ö÷ÒªµÄÉúÎïѧ»îÐÔ¼°ÆäÔÚÁÙ´²ÖÎÁÆÖеÄÓ¦Óᣠ'42$O
}r@dZBp:
2. Çë±È½ÏµÚ¢ñÐÍ(ËÙ·¢ÐÍ)³¬Ãô·´Ó¦ÓëµÚ¢ôÐÍ(³Ù·¢ÐÍ)³¬Ãô·´Ó¦µÄ·¢²¡Ìص㡣 Bz_'>6w
f/O6~I&g
3. ÊÔÊö·ÖÃÚÐÍIgA(secretory IgA)µÄ½á¹¹ÌصãºÍºÏ³É·ÖÃÚ¹ý³Ì¡£ SC~k4&xy
+`GtZnt#
4. ÊԱȽÏT¡¢BÁܰÍϸ°ûϸ°ûĤ±íÃæ·Ö×Ó(Èç±íÃæ¿¹Ô¡¢±íÃæÊÜÌåµÈ)µÄÒìͬµã¡£ :CE4<
{V
=${.*,o
Èý. ÎÊ´ðÌâ(ÿÌâ14·Ö,¹²28·Ö¡£Çë×¢Ò⣺ÿλ¿¼ÉúÖ»ÄÜ´Ó1¡¢2ÌâÖÐѡһÌâ,3¡¢4ÌâÖÐѡһÌâ,¹²´ðÁ½Ìâ,¶à´ðÕß²»¼Æ·Ö¡£) 1. Ŀǰ¼ì²âϸ°ûÒò×ÓÖ÷ÒªÓÐÉúÎïѧ»îÐÔ¼ì²â·¨ºÍÃâÒßѧ¼ì²â·¨,Çë¾ÙÀý·Ö±ðÐðÊöÁ½ÖÖ·½·¨µÄʵÑéÔÀí¡£ 7C7.}U
uRko[W(
2. ΪÁ˱ÜÃâIgG¿¹ÌåFc¶Î·ÇÌØÒìÐÔ×÷ÓÃ,³£Ó¦ÓÃθµ°°×øˮ½âµÄF(ab¡¯)2¶Î,ÊÔÎÊÈçºÎÓ¦ÓÃSDS-PAGE·½·¨¶ÔF(ab¡¯)2½øÐмø¶¨? ?yS1|CF%&y
\PE;R.v_:
3. ÊÔÊö¿¹Ö×Áö»ùÒò¹¤³Ì¿¹ÌåµÄÑо¿½øÕ¹¡£ @/<UhnI
(|^m9v0:
4. ÊÔÊö¿¹²¡¶¾»ùÒò¹¤³Ì¿¹ÌåµÄÑо¿½øÕ¹¡£ ¡¡ aq$ hE-{28
A!bG 2{r
µÚËľüÒ½´óѧһ¾Å¾ÅÎåÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ).5X
k B>
F(^
ѧ¿Æ×¨Òµ£ºÃâÒßѧ¡¢´«È¾²¡Ñ§¡¢Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿£ºÃâÒßѧ 4uIYX
h )
Wp
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© qazA,|L!
#; ?3kuq(
1. immunoglobulin gene rearrangement GjhTF|
3^y(@XFt
2. the common chain of cytokine receptor (or a cytokine receptor subunit shared by some cytokine receptors) G7CeWfS
p +i1sY
3. flow cytometry(FCM) W r/-{Wt
yQ2=d5'V`
4. carrier effect 2 kDsIEA
B'}?cG]
5. positive selection of T lymphocytes in thymus f4f2xe7\Q
{.:$F3T
6. mouse TH1(Th1) and TH2(Th2) subsets @V*dF|# /
KG'i#(u[
7. perforin (pore-forming protein ,PFP) 3 ~v
1 7
5BhR4+1J
8. ADCC(antibody-dependent cell-mediated cytotoxicity) o
<q*3L5
H-kX-7C
9. SH-2(src-homology region 2) &
N7ji
VPUVPq~
&
10. Ab2¦Â (internal image) _VrY7Mz:r
n<ZPWlJ
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© II\&)_S.4
S0,\{j
1. ½üÄêÀ´ÔÚÈËÀà°×ϸ°û·Ö»¯¿¹Ô(CD)Ñо¿ÁìÓòÖÐÓÐÄÄЩÖ÷Òª½øÕ¹? =gB5JB<}2
rJ!cma
2. ²ÎÓë»î»¯Tϸ°ûÓë»î»¯Bϸ°ûÏ໥×÷ÓõķÖ×ÓÖ÷ÒªÓÐÄÄЩ?¼òÊöÆä½á¹¹ºÍ¹¦ÄÜ? ]O@$}B];)
7>E.0DP
3. ÊÔÊöHLAÔÚÁÙ´²ÉϵÄÖ÷ÒªÓ¦Óᣠ]b4WfIu
Cx7-I0!
4. Àý¾ÙÈýÖÖ´ÓÈËÍâÖÜѪµ¥¸öºËϸ°û(PBMC)Öд¿»¯Tϸ°ûµÄ·½·¨,·Ö±ðÐðÊöÆäʵÑéÔÀíºÍÖ÷Òª²Ù×÷²½Öè¡£ ZitM<Qi&y
ZaFt4#
5. ÆÀ¼Ûºìϸ°ûÉú³ÉËØ(EPO)¡¢¸ÉÈÅËØ(IFN)ºÍ¼¯Âä´Ì¼¤Òò×Ó(CSF)ÔÚÁÙ´²Ä³Ð©¼²²¡µÄÓ¦ÓᣠD|;O9iks#
.G0 N+)
Èý. Ñ¡ÔñÎÊ´ðÌâ(ÿÌâ10·Ö,¹²20·Ö¡£Çë°´±¨¿¼×¨Òµ´ðÌâ,Èç´ð·Ç±¾×¨ÒµÌâ»ò¶à´ðÌâ¾ùÊÓΪÎÞЧ¡£) $]v}X},,
1vj/6L
ÃâÒßѧרҵ£º ,WT>"9+
{0zn~+
1. ÊÔÊöϸ°ûÒò×ÓÊÜÌåÖÐ,Ig³¬¼Ò×å¡¢ÔìѪÒò×ÓÊÜÌ峬¼Ò×å¡¢Éñ¾Éú³¤Òò×ÓÊÜÌ峬¼Ò×åÒÔ¼°Ç÷»¯Òò×ÓÊÜÌ峬¼Ò×åµÄÖ÷Òª½á¹¹Ìصã,ÿ¸ö³¬¼Ò×åÀý¾Ù³ö2¸ö³ÉÔ±¡£ V`V\/s gj
rd%%NnT"
2. ÊԱȽÏÈËT¡¢BÁܰÍϸ°ûϸ°ûĤ±íÃæ·Ö×Ó(±íÃæ±ê¼Ç)µÄÒìͬµã,ËüÃÇ·Ö±ð²ÎÓëÄÄЩÖ÷ÒªµÄÃâÒß¹¦ÄÜ? Zi!Ta"}8
o96C^y{~S
´«È¾²¡Ñ§×¨Òµ£º ($[wCHU`!
V$^jlWdR
1. ÈËÀàÃâÒßȱÏݲ¡¶¾(HIV)¸ÐȾÈËÌåºó,ÃâÒß¹¦Äܿɷ¢ÉúÄÄЩÖ÷ÒªµÄ±ä»¯?»úÀíÊÇʲô?ÈçºÎ½øÐÐÏàÓ¦µÄÃâÒßѧ¹¦Äܼì²â£¿ NxT"A)u
Rj8%% G-pt
2. ÇëÆÀÊöÉö×ÛºÏÕ÷³öѪÈȲ¡¶¾(HFRSV)¸ÐȾºó»úÌåÃâÒßѧ±ä»¯µÄÓ벡ÀíËðÉ˵ĹØÏµ¡£ C8N)!5(A
|c_qq Bd
Ïû»¯×¨Òµ£º vF$i"^;tJ;
B/?
L$m
1.ÊÔÊöÓëÏû»¯ÏµÍ³ÓйصÄÖ×ÁöÏà¹Ø¿¹ÔÑо¿µÄ½øÕ¹¡£ sp9gz~Kq
y_]+;% w:
2.¼òÊöճĤÏà¹ØÁܰÍÑù×éÖ¯(mucosal assiociated lymphoid tissue,MALT)µÄ×é³ÉºÍ¹¦ÄÜÌØµã¡£·ÖÃÚÐÍIgAÊÇÈçºÎ½øÐкϳɺͷÖÃÚµÄ? eL!41_QI
~/
%Xm<
µÚËľüÒ½´óѧһ¾Å¾ÅÁùÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ÃâÒßѧÊÔÌâ =bVPHrKNQ
2z.ot'
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£©
{pzj@b 1S
s}D>.9
1. Fas(CD95)/FasL yU$MB,1
/r}L_w
I
2. common chain of cytokine receptor )8Va%{j
WWT1= #"
3 . TCR/CD3 complex b}J%4Lx%m
3Ob.OwA
4. negaive selection of thymocytes ~z,o):q1}
)P$(]{
5. artificial active immune &W `xZyb3
^;C&
6. anti-idiotypic |HazM9=
n*4`Tduu^
7. IgSF 2*Z2uV^
h}b:-a
8. Integrin O5\r%&$xd
LQ0/oYmNc
9. chemokine OvdT* g=8*
UD I{4+z
10. B7/CD28 sFU< PgV
qsj{0 Go
¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²60·Ö£© =8^+M1I
7Z-j'pq
1. ±È½ÏMHC¢ñºÍMHC¢òÀ࿹ԲÎÓëµÄ¼Ó¹¤Ìá³Ê¿¹ÔµÄ¹ý³Ì¡£ XTol|a=
Uj@th
2. ±È½ÏCTLºÍNKɱÉ˰Ðϸ°ûʱʶ±ðºÍɱÉË»úÖÆµÄÌØµã¡£ 6r7>nU&d
'r;mm^cS?
3. ±È½ÏÃâÒßѧ¼ì²â·¨ºÍÉúÎïѧ»îÐÔ¼ì²â·¨¼ì²âϸ°ûÒò×ÓµÄÓÅȱµã¡£ dBWny&
6Z\ aJ
4. ·¢ÏÖÒ»ÖÖеİ×ϸ°û·Ö»¯¿¹Ô»òÖ×ÁöÏà¹Ø¿¹Ô,²¢ÖƱ¸Á˵¥¿Ë¡¿¹Ìå,ÊÔÉè¼ÆÊµÑé·½°¸¿Ë¡´Ë»ùÒò¡£ ;m/e|_4;y
0.GFg${v`
5. Ñ¡ÔñÏÂÊöÖÐÒ»¸öרÌâ,ÐðÊöÎÒ¹úÔÚÕâÒ»Ñо¿ÁìÓòµÄÏÖ×´¼°ÃæÁÙµÄÌôÕ½1)Ö×ÁöÃâÒߣ»(2)»ùÒòÖÎÁÆ£»(3)CD¿¹Ô¡£ 4;`z6\u9-
MlO OB
µÚËľüÒ½´óѧһ¾Å¾ÅÆßÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÃâÒßѧÊÔÌâ 1 $E(8"l
ttP7-y
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© 5#Er& 6s
X+vKY
1. B7/CD28 'u,|*o
|k
a _Zy
2. Th1 subset jP@ @<dt
(*-wiL
3. seven predicated transmembrane domain receptor superfamily£¨STR superfamily£© \S}/2]* 1
#~0N
k6*u
4. antibody affinity maturation p1N}2]e
-jH|L{Iyq}
5. AP-1 hgU;7R,?ir
a~}q]o?j
6. single chain variable fragment£¨ScFv£© hBgE%#`s
i_qY=*a?y
7. NK cell receptor ZmK=8iN9J
;zCUx*{
8. Zinkernagel-Doherty phenomenon n 0!8)Sth
`46~j
9. Ig fold 6w.E Sm
}'[>~&/"
10. CD40/CD40L ;i@S}LwL
-^&=I3bp
¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²36·Ö£© "@ >6<(Ki
=<]`'15"V
1. ÊÔÊöÐØÏÙ΢»·¾³¶ÔÐØÏÙϸ°ûµÄÑ¡Ôñ×÷Óü°ÆäÓëTϸ°û¹¦ÄÜÐÔÑÇȺÐγɵĹØÏµ¡£ J4bP(=w!
Emlj,c<?
j
2. ÊÔÊöÌåÒºÃâÒßÓ¦´ðµÄ¹æÂÉ£¬»ØÒä·´Ó¦ºÍ¿¹ÌåÀà±ðת»»µÄ»úÖÆÊÇʲô£¿ zlMh^+rMX
^'3c%&Zf3
3. ÊԴӽṹºÍ¹¦ÄܵȽǶȣ¬²ûÊö°×ϸ°û·Ö»¯¿¹Ô£¨CD£©¡¢Õ³¸½·Ö×Ó£¨integrin£©ºÍÃâÒßÇòµ°°×³¬¼Ò×壨IgSF£©ÈýÀà·Ö×ÓµÄÏ໥¹ØÏµ¡£Ä¿Ç°ÔÚÕâÒ»ÁìÓòÖÐÖ÷ÒªÑо¿ÈȵãÊÇʲô£¿ 9r%fBiSk
G,C`+1$*
Èý. ÎÊ´ðÌ⣨24·Ö£¬µÚ1ÌâΪÃâÒßѧרҵ¿¼ÉúÊÔÌ⣬µÚ2ÌâΪѪҺ²¡Ñ§¿Æ¿¼ÉúÊÔÌ⣬µÚ3ÌâΪÏû»¯ÄÚ¿Æ¿¼ÉúÊÔÌ⣬ֻÔÊÐí´ð±¾×¨ÒµÊÔÌ⣩ OP/DWf
eV7;#w<]
1. ÊԱȽÏTCRºÍBCR½á¹¹¼°Æäʶ±ð¿¹Ô¡¢ÁܰÍϸ°û»î»¯ÐźŵķÖ×Ó»úÀí¡££¨ÃâÒßѧרҵ£©¡£ Y?^liI`#
"FHJ_$!
2. ÊÔÊö°×Ѫ²¡ÃâÒßѧ·ÖÐÍÀíÂۺͷ½·¨µÄÑо¿½øÕ¹¡££¨ÑªÒº²¡Ñ§×¨Òµ£©¡£ yr\ClIU
TdFU,
3. ÊÔÊöÖ×ÁöÒßÃçµÄÑо¿½øÕ¹¡££¨Ïû»¯ÄÚ¿Æ×¨Òµ£©¡£ sx?IIFF
8eqTA8$?
Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ £¨ÃâÒßѧרҵºÍרҵ»ù´¡£© 99yWUC,
CL0lMZ
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© ?/|Xie
rHKO13WF
1.Co-stimulators (or co-stimulating molecules) =lAjQt
_[rFnyC+0V
2.NK-kB IuY9Q8
U["0B8
3.Immunoglobulin superfamily |z)s9B;:#i
Y` }X5(A@
4.antigen-presenting cell (APC) cWW?@_
oq7G=8gTp
5.death domain fd[N]I3
8-#kY}d.
6.CCR and CXCR 1L,L/sOwB&
NP;W=A F
7.Lectin (or mitogen) ZR1U&<0c@
44KoOY_
8.Clusters of differentiation, CD) 4Y(@
KU
b
hywcj\[
9.B7 family Zv!`R($
u1meysa{0
10.Cytotoxic T lymphocyte, CTL) vAX ( 3
l cl|o3yQ
11.IL-15 and IL-15 receptor (IL-15R)
GK/Po51
jn^X{R\
12.MHC restriction ET.jjV
,D{7=mDVm
13.Affinity-chromatography w(@r-2D"
n^nE&'[?0g
14.Cyctosprin A, CsA N,TV?Q5l7
m?kiGC&m
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) %jHm9{|X
dk&e EDvfd
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© 2|;|C8C
(H_dZL
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 m|q,ixg
! VR&HEru
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ ,)`_?^\$f
IHTimT?
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£ !R8%C!=a
v_XN).f;
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© >W> rhxU
C&z!="hMhR
ÃâÒßѧרҵ£º JX0M3|I=
W'4/cO
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ PIH\*2\/
wlNL;W@w
Ïû»¯ÄÚ¿Æ£º 2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ SrKitSG
)=f}vHg$
ѪҺ²¡Ñ§×¨Òµ£º 3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿ u
8o!
htB7
j(
Ò»¾Å¾ÅÄê¾Å²©Ê¿ÉúÈëѧ¿¼ÊÔÊÔÌâ (רҵ»ù´¡: ÃâÒßѧ) VgbNZ{qk@
U =J5lo
Ò».Ãû´Ê½âÊÍ(ÿÌâ5·Ö,¹²45·Ö) [+o{0o>
Lip#uuuXXN
1. ADCC(antibody dependent cell-mediated cytotoxicity) 8;g
i8Y
UIEvwQ
2. »·æß¾úËØ(cyclosporin) a*(Zb|g
?d%)R*3IX
3. KIR(killer cell inhibitory receptor) d~8U1}dP
9(]_so24,
4. HLDA(human leucocyte differentiation antigen) _4>DuklH,
+ nR("Il
5. Interleukin 18(IL-18) >Cr"q*
}tt%J[
6. ÕûºÏËØ(integrin) g/C 7wc
eP~3m
7. Fas/FasL :Pq&l.
x[t?hl=:
8. FcR(ÃâÒßÇòµ°°×Fc¶ÎÊÜÌå) vGyQ306
aX.BaK6I
9. ϸ°û¼äÕ³¸½·Ö×Ó(ICAM) F,_cci`p
wA
{)9.
10. Th1/Th2 L~ax`i1:"
6Y [&1c8
11. »ùÒòÒßÃç(DNAÒßÃç) ~"S5KroN
!&OdbRHM
12. chemokines and chemokine receptor ]yKwH 9sl
s-*N_Dv
13. ÃâÒßÄÍÊÜ Oi?Q^ISxP
;s3@(OnjZ
14. ¹²´Ì¼¤·Ö×Ó ^I/(9KP#
;2h"YU-b
15. ËÀÍö½á¹¹Óò(death domain) ?bd!JW bg`
3=]/+{B
¶þ.ÎÊ´ðÌâ(µÚ1¡¢2Ìâ¸÷18·Ö,µÚ3Ìâ19·Ö) {;bec%pq0
[
2@Lc3<
1. ÊԱȽÏɱÉËÐÔTϸ°û(CTL)Óë×ÔȻɱÉËϸ°û(NK)ÔÚɱÉ˰Ðϸ°û¹ý³ÌÖÐ,ʶ±ðϸ°û¶¾¼°½éµ¼ÃâÒß¹¦ÄÜÓкβ»Í¬? 6Hc25NuQZ
L,_U co
2. 70Äê´úÒÔÀ´,ÓйØIgºÍÌåÒºÃâÒßÑо¿´æÔÚÒÔϼ¸ÏîÖØ´ó·¢ÏÖºÍÍ»ÆÆ¶ø»ñµÃҽѧºÍÉúÎïѧŵ±´¶û½±,Çë·Ö±ð²ûÊöËüÃǵÄÀíÂÛÒâÒå¼°ÔÚҽѧʵ¼ùÖеÄÓ¦Óᣠ&>B
|?d
_)-2h[
£¨1£©1972Ä꣺θµ°°×øºÍľ¹Ïµ°°×øˮ½âIg£¬»ñµÃFab¡¢Fc¡¢F£¨ab¡¯£©2µÈƬ¶Î b
<fN,U<k
j5Yli6r?3-
£¨2£©1977Ä꣺·ÅÉäÃâÒß·¨ RW>F %P
rGH7S!\AM
£¨3£©1984Ä꣺ÁܰÍϸ°ûÔÓ½»ÁöºÍµ¥¿Ë¡¿¹Ìå unL1/JY z
9LQy0Gx
£¨4£©1987Äê: Ig»ùÒòµÄ½á¹¹ 3. ½üÄêÀ´ÔÚÖ×ÁöÃâÒßÑо¿ÁìÓòÖÐÓÐÄÄÐ©ÖØÒª½øÕ¹?ÊÔÊöµ±Ç°Ìá¸ß»úÌ忹Ö×ÁöÃâÒßµÄÖ÷Òª²ßÂÔ¡£ 5}NO~Xd<
17Q*
<iCs
Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(ÃâÒßѧרҵ) ÎÊ´ðÌâ(ÿÌâ25·Ö) !oV'
!x:w2
1. ÊԱȽÏTϸ°ûÊÜÌ壨TCR£©¡¢Bϸ°ûÊÜÌ壨BCR£©ºÍNKϸ°ûÊÜÌ壨NKCR£©µÄ×é³É£¬Ê¶±ðÅäÌåÒÔ¼°ÐźÅתµ¼µÄÒìͬµã¡£ [0+5 Gx
,Ur~DXY
2. ÒÔÐØÏÙÒÀÀµ¿¹Ô´Ì¼¤»úÌå²úÉú¿¹ÌåµÄÃâÒßÓ¦´ðΪÀý£¬Tϸ°ûºÍBϸ°ûÊÇÈçºÎÏ໥×÷Óã¿ÓÐÄÄЩճ¸½·Ö×Ӻ͹²´Ì¼¤·Ö×Ó²ÎÓëT¡¢Bϸ°ûµÄÏ໥×÷Óã¿ RDG,f/L2
8DrKq]&
3. Éö×ÛºÏÕ÷³öѪÈÈ(HFRS)²¡¶¾µÄ½á¹¹»ùÒòÒѾ¸ãÇå³þ,ΪÁË֤ʵHFRS²¡¶¾¸ÐȾ»úÌå(ÒÔBalb/CСÊóΪÀý)¿É²úÉúHFRS²¡¶¾ºËÒ¿ǵ°°×(NP)ÌØÒìÐÔCTL,²¢ÔÚÃâÒß·À»¤ÖÐÆðÖØÒª×÷ÓÃ,ÇëÓ¦ÓÃÃâÒßѧÀíÂۺͷ½·¨,Éè¼ÆÒ»ÏµÍ³ÊµÑé,¼ÓÒÔ֤ʵ¡£ 4. Àý¾Ù¶þ¸ö½üÄêÀ´Ï¸°ûºÍ·Ö×ÓÃâÒßѧÑо¿ÖгöÏÖµÄеÄÈȵã,Çë·Ö±ðÆÀÊöÆäÑо¿ÒâÒå¡¢·¢Õ¹Ç÷ÊÆÒÔ¼°Ó¦ÓÃǰ¾°¡£